New Strategies to Enhance Smoking Cessation

This study is testing a new educational video designed to help people quit smoking. The video explains how nicotine affects the brain and how medications like varenicline (Chantix) and nicotine replacement therapies work. Researchers want to understand if this video, along with technology support, can help people attend smoking cessation programs and successfully quit. You might be able to join if you are 18-75 years old, smoke at least 10 cigarettes a day, and are not currently using other smoking cessation medications. The study will measure how well people like the video and if it helps them quit smoking over 24 weeks. The current recruitment status is unclear.

Study design: This interventional study plans to enroll 94 participants. It is testing an educational video intervention.
What's involved: You would need to agree to complete surveys and measures within the study. The study will measure outcomes at 24 weeks.
Compensation: Not stated in the trial record.
Follow-up: Participants will be followed for 24 weeks to assess the video's acceptability and smoking outcomes.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

New Strategies to Enhance Smoking Cessation

Recruiting

NAAges 18–75InterventionalPrevention

University of Chicago

~94 participants

Updated 2025-06-11 on ClinicalTrials.gov

What's tested:Educational Video

At a glance

Recruiting sites

1 of 1 listed site is recruiting right now

RecruitingSuspended, closed, or not yet open

What they're measuring

Acceptability of the experimental video intervention

Measured over 24 weeks

+2 more outcomes measured

Conditions

Smoking Cessation

Where it's being run

1 sites across 1 states

Illinois1

Study leadership

Andrea C. King · PRINCIPAL_INVESTIGATOR · University of Chicago

Who to contact

Clinical Trials Intake

[email protected]

1-855-702-8222

Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime

Eligibility criteria

Inclusion

Patients must smoke at least 10 cigarettes/day and do not currently use a smoking cessation medication.

Ages 18-75.

Agree to complete surveys and measures within study.

Ability to understand English and the willingness to sign a written informed consent document.

Exclusion

Patients who are receiving any other smoking cessation medications.

Patients who are pregnant and/or lactating.

Patients with psychiatric contraindications that can prevent adherence to protocol or use of intervention tools in study. For inclusivity on trial, psychiatric contraindications and ability for patient to participate in trial will be assessed on an individual basis by study investigator.

Patients who have a contraindication with varenicline.

What this trial measures

Acceptability of the experimental video intervention24 weeks
This will be assessed using a modified version of the Client Satisfaction Questionnaire which assesses items such as quality, effectiveness, and intrusiveness on the 10-point Likert scale (0=not at all, 10=very much).
Determine whether provision of technology access and support will improve program attendance and smoking outcomes24 weeks
This will be assessed using a modified version of the Client Satisfaction Questionnaire specific to technology component which assesses items such as quality, effectiveness, and intrusiveness on the 10-point Likert scale (0=not at all, 10=very much).
Trial feasibilityEnd of study recruitment (6 months)
ability to enroll and follow-up with the planned number of participants within the specified time frame.

Trialytics